Justin A Ezekowitz Selected Research

Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)

2/2016	Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
3/2015	Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
6/2013	Acute decompensated heart failure: update on new and emerging evidence and directions for future research.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Justin A Ezekowitz Research Topics

Disease

143	Heart Failure 01/2022 - 09/2004
26	Atrial Fibrillation 01/2022 - 12/2003
16	Stroke (Strokes) 01/2022 - 12/2003
13	Dyspnea (Shortness of Breath) 01/2020 - 04/2012
12	Myocardial Infarction 01/2022 - 10/2005
8	Hemorrhage 12/2020 - 09/2011
8	Acute Coronary Syndrome 10/2018 - 07/2012
8	ST Elevation Myocardial Infarction 12/2015 - 04/2006
7	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2008
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2007
7	Diabetes Mellitus 01/2020 - 12/2003
7	Embolism (Embolus) 01/2019 - 09/2011
6	Infarction (Infarctions) 10/2018 - 04/2006
6	Left Ventricular Dysfunction 05/2013 - 08/2007
5	Inflammation (Inflammations) 01/2022 - 07/2012
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
5	Heart Diseases (Heart Disease) 01/2019 - 04/2006
5	Systolic Heart Failure 09/2017 - 09/2004
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 04/2013
4	Anemia 11/2021 - 02/2005
4	Hypertension (High Blood Pressure) 02/2021 - 12/2003
4	Hypotension (Low Blood Pressure) 01/2019 - 11/2014
4	Chest Pain (Chest Pains) 01/2017 - 10/2014
3	COVID-19 01/2022 - 02/2021
3	Neoplasms (Cancer) 01/2020 - 01/2019
3	Shock 10/2018 - 09/2009
3	Hyperoxia 10/2016 - 12/2011
2	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2017
2	Amyloidosis 01/2022 - 01/2020
2	Cardiotoxicity 01/2022 - 03/2017
2	Mitral Valve Insufficiency (Mitral Regurgitation) 10/2021 - 01/2020
2	Acute Kidney Injury (Acute Renal Failure) 02/2021 - 10/2018
2	Obesity 06/2020 - 01/2018
2	Edema (Dropsy) 01/2020 - 11/2018
2	Body Weight (Weight, Body) 01/2019 - 01/2016
2	Heart Arrest (Cardiac Arrest) 12/2018 - 03/2003
2	Ventricular Fibrillation 12/2018 - 03/2003
2	Ventricular Tachycardia 12/2018 - 03/2003
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018 - 03/2003
2	Death (Near-Death Experience) 11/2017 - 05/2011
2	Weight Gain 09/2014 - 09/2013

Drug/Important Bio-Agent (IBA)

41	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 04/2006
20	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
17	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 04/2006
15	SodiumIBA 01/2022 - 11/2014
11	vericiguatIBA 01/2022 - 11/2020
11	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 09/2011
9	apixabanIBA 01/2022 - 09/2011
7	CreatinineIBA 02/2021 - 09/2014
7	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2003
6	Dietary SodiumIBA 01/2022 - 02/2015
6	TroponinIBA 02/2021 - 10/2014
5	Natriuretic PeptidesIBA 01/2017 - 04/2006
4	Hemoglobins (Hemoglobin)IBA 11/2021 - 02/2005
4	AnticoagulantsIBA 12/2020 - 01/2015
4	Oxygen (Dioxygen)IBA 01/2019 - 10/2016
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2017 - 12/2003
3	ChloridesIBA 12/2021 - 05/2021
3	Vitamin K FDA Link 12/2020 - 09/2011
3	Sodium-Glucose Transporter 2 InhibitorsIBA 02/2020 - 01/2020
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2020 - 01/2015
3	LigandsIBA 02/2018 - 03/2015
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 12/2003
3	Urea (Carbamide)FDA LinkGeneric 06/2017 - 09/2013
3	NitrogenIBA 06/2017 - 09/2013
3	Mineralocorticoid Receptor AntagonistsIBA 01/2017 - 04/2012
3	Eplerenone (Inspra)FDA LinkGeneric 10/2016 - 02/2009
3	coenzyme Q10 (CoQ10)IBA 04/2016 - 12/2014
3	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 02/2016 - 06/2013
3	DiureticsIBA 08/2015 - 03/2014
3	pexelizumabIBA 10/2010 - 04/2006
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 03/2017
2	Cardiac MyosinsIBA 01/2022 - 03/2016
2	omecamtiv mecarbilIBA 01/2022 - 03/2016
2	BilirubinIBA 06/2021 - 05/2021
2	Uric Acid (Urate)IBA 06/2021 - 05/2021
2	AlbuminsIBA 06/2021 - 05/2021
2	Hormones (Hormone)IBA 06/2021 - 05/2021
2	Biological ProductsIBA 02/2021 - 01/2020
2	omega-Chloroacetophenone (Mace)IBA 02/2021 - 01/2017
2	Neprilysin (Neutral Endopeptidase)IBA 01/2020 - 01/2015
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2019 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 10/2018 - 07/2012
2	Sar-Arg-Val-Tyr-Ile-His-Pro-Ala-OHIBA 02/2018 - 03/2015
2	Type 1 Angiotensin ReceptorIBA 02/2018 - 08/2017
2	Furosemide (Lasix)FDA LinkGeneric 02/2016 - 08/2015
2	Pharmaceutical PreparationsIBA 01/2016 - 01/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 09/2015 - 11/2014
2	Dopamine (Intropin)FDA LinkGeneric 04/2015 - 12/2011

Therapy/Procedure

51	Therapeutics 01/2022 - 03/2003
9	Patient Readmission 01/2020 - 07/2008
7	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2020 - 03/2003
7	Critical Care (Surgical Intensive Care) 10/2019 - 12/2014
6	Length of Stay 02/2021 - 07/2013
6	Transjugular Intrahepatic Portasystemic Shunt 01/2021 - 01/2008
6	Cardiac Resynchronization Therapy 01/2017 - 09/2004
4	Percutaneous Coronary Intervention 01/2022 - 09/2009
3	Drug Therapy (Chemotherapy) 12/2020 - 09/2004
2	Aftercare (After-Treatment) 01/2020 - 01/2005
2	Sodium-Restricted Diet (Diet, Sodium Restricted) 03/2016 - 01/2015